LJI scientists publish first head-to-head comparison of four COVID-19 vaccines
Correction: A previous version of this article incorrectly stated that “Participants given the Janssen/J&J vaccine had the highest percentage of
Correction: A previous version of this article incorrectly stated that “Participants given the Janssen/J&J vaccine had the highest percentage of
As California emerges from Omicron, other places are again in lockdown or facing record caseloads after trying and failing to
Four COVID-19 vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2.
New agreement paves the way for better mouse models to study how the human immune system fights SARS-CoV-2
When a T cell makes up its mind to kill, it does not mess around.
Most vaccines include particles called adjuvants. But not all adjuvants are created equal.
New LJI research shows how a range of critical immune cells respond to SARS-CoV-2
The international recognition reflects how LJI research is valued by scientific peers
La Jolla Institute scientists team up with Brigham and Women's Hospital to guide the development of vaccines against the coronavirus family
Mexican sculptor assembles an emotional tribute to COVID-19 research
Even elderly survivors show a strong, persistent immune memory
LJI-led Coronavirus Immunotherapeutic Consortium identifies antibody 'communities' with power to stop SARS-CoV-2 variants